Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Healthcare Industry News Syngenta expands global footprint in agricultural biologicals with new acquisitions and facilities Syngenta advances global leadership in agricultural biologicals with new acquisitions, R&D centers, and a USD 20B market outlook by 2030. Explore strategy. byPallavi MadhirajuJuly 1, 2025